Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: INERT PACKAGE FOR OVERSEA MARKET
Transportation: Ocean,Land,Air,Express
Supply Ability: 10000KGS MONTHLY
Port: QINGDAO,SHANGHAI,TIANJIN
Payment Type: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
Product name:Belviq CAS 856681-05-5
It is a new type of weight loss drug and an orally effective selective 5-HT2c receptor agonist. The drug is approved for obese or overweight adults with body mass index|(bodymassindex, BMI)>27, and the patient has at least one weight-related disease (Such as hypertension, type 2 diabetes ). It can effectively reduce the weight of obese and overweight patients, improve obesity-related metabolic indicators, and is well tolerated.
product name | Belviq |
CAS | 856681-05-5 |
EINECS | 1592732-453-0 |
MF | C11H17Cl2NO |
MW | 250.16 |
Product Categories : API Intermediates > Lorcaserin HCL Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.